Vendor, Esch-Sur-Alzette, LUX
Organotherapeutics GMBH
UEI KY6GHXV1CLK3, CAGE BTQT1
1 award and $253,868 obligated between September 30, 2026 and September 30, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $253,868 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40126P00334Purchase Order, September 30, 2026, Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Eo 14398 Human Hindbrain OrganoidsNAICS 541714, PSC B504 | $253,868 |
- Product and service codes
- B504 Chemical/Biological Studies and Analysis
- Transactions
- 1 across 1 awards